SNF8

SNF8 (EAP30/VPS22) is a subunit of the ESCRT-II complex that drives sorting of ubiquitinated cell-surface receptors into multivesicular bodies for lysosomal degradation, and which has been repeatedly captured acting in the nucleus to control gene transcription (PMID:17714434, PMID:10419521). On endosomes, SNF8 localizes to compartments containing EGFR, Hrs and other ESCRT components, and its depletion blocks degradation of EGFR and CXCR4, causes receptor accumulation on the limiting membrane of early endosomes, and yields aberrantly small multivesicular bodies; this engagement occurs after termination of EGF-stimulated ERK signaling (PMID:17714434). Membrane recruitment of the ESCRT-II subunits SNF8 (VPS22) and VPS36 is directed by the Rab7 effector RILP, whose N-terminal half binds SNF8, linking the late endocytic machinery to early ESCRT sorting (PMID:17010938, PMID:16857164). Independently of trafficking, SNF8 is a subunit of the ELL transcription elongation complex, where it binds ELL directly and derepresses ELL-mediated inhibition of RNA polymerase II (PMID:10419521), and a nuclear pool of SNF8 forms a virus-inducible complex with IRF3 and the co-activator CBP, acting downstream of IRF3 activation to promote IRF3 binding at interferon and ISG promoters and drive antiviral type I and III interferon responses (PMID:29084253). SNF8 also binds the N-terminal cytoplasmic domain of TRPC6 and enhances TRPC6 channel current and downstream NFAT activation without changing channel surface levels (PMID:23171048). Work in model organisms shows the ortholog negatively regulates meiotic spindle pole body maturation upstream of the pericentrin ortholog Pcp1 in fission yeast (PMID:15992541) and acts in the DAF-16/FOXO longevity pathway in C. elegans by supporting DAF-16 nuclear localization (PMID:32829877).

1. 1995 Medium

   Established the founding loss-of-function phenotype: SNF8 was unknown in function until yeast genetics showed it is required for glucose-derepression of SUC2 and is functionally related to SNF7, defining a discrete gene group distinct from the SNF1/SNF4 cluster.

   Evidence Gene disruption, genetic epistasis, and invertase derepression assay in S. cerevisiae

   PMID:7785322

   Open questions at the time

   • No molecular mechanism for how SNF8 derepresses transcription
   • Relationship to membrane trafficking not yet appreciated
   • Mammalian ortholog function untested
2. 1999 Medium

   Connected the yeast gene to a mammalian transcription mechanism: EAP30/SNF8 was found to be an ELL-complex subunit that binds ELL and relieves ELL's inhibition of RNA Pol II, giving a biochemical activity to the derepression phenotype.

   Evidence In vitro transcription assay, protein interaction studies, and sequence homology analysis

   PMID:10419521

   Open questions at the time

   • In vitro only; nuclear role not shown in cells
   • Stoichiometry/structure of EAP30 within Holo-ELL unresolved
   • Does not address any membrane function
3. 2005 Medium

   Revealed an organelle-biogenesis role: the fission yeast ortholog Dot2 negatively regulates meiotic spindle pole body maturation, placing it upstream of the pericentrin ortholog Pcp1.

   Evidence Genetic mutation, electron microscopy, and pcp1-suppression epistasis in S. pombe meiosis

   PMID:15992541

   Open questions at the time

   • Mechanistic link between ESCRT-II function and SPB control unclear
   • Conservation to mammalian centrosomes untested
   • Whether this depends on ESCRT membrane activity unknown
4. 2006 Medium

   Identified the recruitment cue for ESCRT-II to endosomes: RILP, the Rab7 effector, binds SNF8/VPS22 via its N-terminal half and controls membrane recruitment of ESCRT-II, bridging late-endosomal and early-sorting machinery.

   Evidence Yeast two-hybrid, co-immunoprecipitation, domain mapping, and confocal colocalization (two companion papers)

   PMID:16857164 PMID:17010938

   Open questions at the time

   • Single interaction-method class (no structure of the complex)
   • Functional consequence of disrupting RILP-VPS22 binding not quantified
   • How Rab7 activity gates the interaction unresolved
5. 2007 High

   Defined SNF8's core cell-biological role and pathway position: as an ESCRT-II subunit it is required for MVB sorting and lysosomal degradation of EGFR and CXCR4, acting after EGF signaling has terminated.

   Evidence siRNA knockdown with receptor degradation, endosome morphology, and ERK signaling readouts

   PMID:17714434

   Open questions at the time

   • Does not resolve how ESCRT-II selects ubiquitinated cargo at this step
   • Structural role within the ESCRT cascade not addressed
   • Specificity for EGFR/CXCR4 vs other receptors untested
6. 2009 Low

   Probed regulation of the nuclear ELL complex: MCM2 binds EAP30 and competes with ELL, indicating a route to modulate Holo-ELL stability/activity.

   Evidence Co-immunoprecipitation and competitive binding assay

   PMID:19819239

   Open questions at the time

   • Single Co-IP/competition assay without functional or transcriptional readout
   • Cellular relevance of competition not demonstrated
   • Not independently confirmed
7. 2012 Medium

   Uncovered a trafficking-independent ion-channel function: SNF8 binds the TRPC6 N-terminal cytoplasmic domain and enhances channel current and NFAT signaling without altering surface channel levels.

   Evidence Yeast two-hybrid, co-IP, whole-cell patch-clamp, NFAT reporter, RNAi, and surface biotinylation

   PMID:23171048

   Open questions at the time

   • Mechanism by which SNF8 potentiates channel gating unknown
   • Physiological context of TRPC6 regulation untested
   • Single lab
8. 2017 High

   Established a distinct nuclear antiviral role: a fraction of EAP30 forms a virus-inducible IRF3-CBP complex acting downstream of IRF3 activation to promote promoter binding and induction of type I/III interferons, a function specific to EAP30 among ESCRT-II subunits.

   Evidence siRNA, co-IP, ChIP, nuclear fractionation, and VSV/HCV antiviral assays

   PMID:29084253

   Open questions at the time

   • How EAP30 partitions between endosomal ESCRT-II and nuclear pools is unresolved
   • Whether this role requires ESCRT-II assembly unknown
   • Signal that triggers nuclear localization not defined
9. 2020 Medium

   Linked SNF8 to longevity signaling: the C. elegans ortholog acts in the DAF-16/FOXO pathway, with knockdown reducing DAF-16 nuclear localization and shortening lifespan in a daf-16-dependent manner.

   Evidence RNAi, genetic epistasis, DAF-16::GFP nuclear localization, lifespan and target-gene expression assays

   PMID:32829877

   Open questions at the time

   • Molecular link between ESCRT-II and DAF-16 trafficking unknown
   • Whether endosomal or nuclear SNF8 function mediates the effect unclear
   • Conservation to mammalian FOXO untested

• How a single ESCRT-II subunit is partitioned and regulated across its membrane-sorting, transcription-elongation, antiviral, channel-modulatory, and spindle/longevity roles remains unresolved.
• No structural model integrating SNF8's endosomal vs nuclear functions
• Signals governing nuclear translocation undefined
• Whether non-ESCRT roles require the intact ESCRT-II complex unknown